Raymond James & Associates’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
WA
Raymond James & Associates's INSP Position: Q3 2024 in Review
Raymond James & Associates increased its Inspire Medical Systems (INSP) stake by 43% in Q3 2024, buying an estimated $195K and bringing the position to 3,720 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.
Raymond James & Associates first reported a position in INSP in Q1 2020 and has held it in 18 quarters since. The position peaked at $3.7M in Q4 2022. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.
- Raymond James & Associates held 3,720 shares of Inspire Medical Systems worth $785K as of Q3 2024.
- Raymond James & Associates bought 1,123 Inspire Medical Systems shares in Q3 2024, an estimated $195K.
- Inspire Medical Systems made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2839 holding.
- Raymond James & Associates first reported a position in Inspire Medical Systems in Q1 2020 and has held it in 18 quarters since.
- Raymond James & Associates's Inspire Medical Systems position peaked at $3.7M in Q4 2022.
- 346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.